| 1. |
|
ipr-rat TDLo:1820 mg/kg (male 10W pre):TER
|
|
JZKEDZ Jitchuken, Zenrinsho Kenkyuho. Central Institute for Experimental Animals, Preclinical Reports. 7 (1981),145. |
| 2. |
|
orl-wmn LDLo:60 mg/kg/10D-I:SYS
|
|
NYSJAM New York State Journal of Medicine. 83 (1983),1057. |
| 3. |
|
orl-man TDLo:43 mg/kg/5D-I:SYS
|
|
NYSJAM New York State Journal of Medicine. 83 (1983),1057. |
| 4. |
|
orl-wmn TDLo:8 mg/kg/1D-I:LIV,BLD
|
|
SMJOAV Southern Medical Journal. 75 (1982),496. |
| 5. |
|
orl-man TDLo:1429 µg/kg:SYS
|
|
NNGAAS Nippon Naika Gakkai Zasshi. Journal of the Japanese Society of Internal Medicine. 72 (1983),1177. |
| 6. |
|
orl-chd LDLo:30 mg/kg
|
|
MJAUAJ Medical Journal of Australia. 2 (1978),335. |
| 7. |
|
orl-man TDLo:45 mg/kg/1W-I
|
|
SMJOAV Southern Medical Journal. 76 (1983),1453. |
| 8. |
|
orl-wmn TDLo:20 mg/kg/3D-I:CVS,BLD
|
|
AHJOA2 American Heart Journal. 105 (1983),870. |
| 9. |
|
orl-rat LD50:880 mg/kg
|
|
YACHDS Yakuri to Chiryo. Pharmacology and Therapeutics. 9 (Suppl 1)(1981),5. |
| 10. |
|
ipr-rat LD50:255 mg/kg
|
|
YACHDS |